Information Journal Paper
APA:
Copy. (2017). TET1 inhibits EMT of ovarian cancer cells through activating Wnt/beta-catenin signaling inhibitors DKK1 and SFRP2. GYNECOLOGIC ONCOLOGY, 147(2), 408-417. SID. https://sid.ir/paper/722805/en
Vancouver:
Copy. TET1 inhibits EMT of ovarian cancer cells through activating Wnt/beta-catenin signaling inhibitors DKK1 and SFRP2. GYNECOLOGIC ONCOLOGY[Internet]. 2017;147(2):408-417. Available from: https://sid.ir/paper/722805/en
IEEE:
Copy, “TET1 inhibits EMT of ovarian cancer cells through activating Wnt/beta-catenin signaling inhibitors DKK1 and SFRP2,” GYNECOLOGIC ONCOLOGY, vol. 147, no. 2, pp. 408–417, 2017, [Online]. Available: https://sid.ir/paper/722805/en